Formulation & feasibility
Evaluate the proposed formulation, ingredient specifications, stability needs and manufacturing feasibility.
LIVERBIOME™ · FOUNDING SUPPORTERS
We’re developing our first proprietary intervention at BeHealthWise. Join the Founding Supporters community to follow the science, the development journey and the steps towards a potential launch.
2
Founding Supporters
Registered interest in the LIVERBIOME™ journey.
Free, non-binding expressions of interest. Not pledges or funds raised.
Free and non-binding. No payment, deposit or pledge is collected on this page.

Conceptual visualization · Product in development
Community count · 2 registered
The count reflects eligible registrations recorded by this page, not pledges or funds raised.
Why the liver
The liver performs hundreds of functions that touch nearly every aspect of metabolic health.
The liver helps process nutrients, store energy and regulate many essential functions. It also interacts with the gut through complex biological pathways that researchers continue to study.
LIVERBIOME™ is being developed around this area of interest. We will distinguish emerging scientific hypotheses from findings established in humans, and assess any eventual product claims against evidence relevant to the finished formulation.
The rationale for researching a biological pathway is not proof that a finished product will produce a particular outcome.
The development journey
These are planned stages, not claims of completed work. Milestones will only be marked complete when they have been verified.
Evaluate the proposed formulation, ingredient specifications, stability needs and manufacturing feasibility.
Define the quality and testing plan, review product classification, and establish what claims may appropriately be made.
Assess production, packaging, supply arrangements, costs and fulfilment requirements before committing to a launch.
Move forward only when the relevant development, manufacturing and regulatory-readiness requirements have been assessed.
Responsible development
A future funding plan will be published only when the budget and assumptions are sufficiently documented.
Formulation & feasibility
Quality testing and technical documentation
Regulatory preparation and claims review
Manufacturing, packaging and fulfilment readiness
This is a list of anticipated categories, not a published budget or a claim that funds have been raised. Phase 1 registrations do not constitute pledges, and no money is collected here.
Founding Supporters
Register your interest to receive development updates and information about any future opportunity to support LIVERBIOME™.
Registration is free and non-binding. It does not guarantee a product, discount, reward, investment opportunity or launch date.
Trust & transparency
We will communicate what is known, what remains uncertain and what needs to happen before a launch.
No. LIVERBIOME™ is in development and is not being offered for purchase through this page.
No. This is a free, non-binding expression of interest. No payment, deposit or pledge is collected.
We are not presenting the finished formulation as clinically proven. Product claims will be assessed against appropriate evidence and applicable requirements.
There is no confirmed launch date. Timing will depend on development, manufacturing, quality and regulatory-readiness considerations.
A future customer-funding or pre-order campaign may be considered. Any price, benefits, delivery estimates, risks and cancellation or refund terms would be disclosed before payments are accepted.
Within the ecosystem
BeHealthWise is a longevity platform, not a supplement company. Products are considered alongside foundational behaviours, evidence and personal context — never as a replacement for them.
LIVERBIOME™ is in development. Product information, availability and claims will follow applicable requirements and be assessed against relevant evidence. This page describes intent, not proven clinical outcomes. Registration is non-binding and does not involve payment or guarantee a product, reward, investment opportunity or launch date.